Sale!

ANO5 Gene Limb-girdle muscular dystrophy autosomal recessive type 2L Genetic Test

4,400 د.إ

-21%

The ANO5 gene limb-girdle muscular dystrophy autosomal recessive type 2L (LGMDR2, formerly LGMD2L) genetic test is a specialized diagnostic tool offered by DNA Labs UAE, aimed at identifying mutations in the ANO5 gene that are associated with this specific form of muscular dystrophy. Limb-girdle muscular dystrophy is a group of genetic disorders characterized by progressive muscle weakness and atrophy, primarily affecting the muscles around the hips and shoulders (the limb-girdle area). The autosomal recessive type 2L variant, associated with mutations in the ANO5 gene, is one of the many subtypes of this condition.

The test, which costs 4400 AED, involves analyzing the patient’s DNA to detect mutations in the ANO5 gene that are known to cause LGMDR2. It is a crucial step for patients showing symptoms of muscular dystrophy, as a definitive genetic diagnosis can help in understanding the progression of the disease, inform treatment options, and allow for genetic counseling for the family. Conducted at DNA Labs UAE, this test is an important resource for individuals and families seeking answers about this specific form of limb-girdle muscular dystrophy.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ANO5 Gene Limb-girdle muscular dystrophy autosomal recessive type 2L Genetic Test

At DNA Labs UAE, we offer the ANO5 Gene Limb-girdle muscular dystrophy autosomal recessive type 2L Genetic Test for AED 4400.0. This test is used to diagnose and identify the symptoms of Limb-girdle muscular dystrophy, autosomal recessive type 2L (LGMD2L).

Test Details

LGMD2L is a genetic disorder characterized by progressive muscle weakness and wasting primarily affecting the muscles of the shoulders and hips. The ANO5 gene is associated with this condition.

The ANO5 Gene Limb-girdle muscular dystrophy autosomal recessive type 2L Genetic Test utilizes NGS (Next-Generation Sequencing) technology to analyze the ANO5 gene for any mutations or variations that may be associated with LGMD2L. By identifying the specific genetic mutation causing the condition, this test can confirm a diagnosis and provide valuable information for genetic counseling, family planning, and treatment decisions.

Test Components and Price

The ANO5 Gene Limb-girdle muscular dystrophy autosomal recessive type 2L Genetic Test is priced at AED 4400.0. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA Card.

Report Delivery

The test results will be delivered within 3 to 4 weeks.

Method

The test utilizes NGS technology for analysis.

Test Type

The ANO5 Gene Limb-girdle muscular dystrophy autosomal recessive type 2L Genetic Test is classified under Neurological Disorders.

Doctor and Test Department

The test is conducted by a Neurologist in the Genetics department.

Pre Test Information

Prior to the test, a clinical history of the patient is required. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with LGMD2L.

It is important to note that genetic testing should be performed by a qualified healthcare professional or genetic counselor, who can interpret the results and provide appropriate guidance and support.

Test Name ANO5 Gene Limb-girdle muscular dystrophy autosomal recessive type 2L Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ANO5 Gene Limb-girdle muscular dystrophy, autosomal recessive type 2L NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ANO5 Gene Limb-girdle muscular dystrophy, autosomal recessive type 2L
Test Details

The ANO5 gene is associated with Limb-girdle muscular dystrophy, autosomal recessive type 2L (LGMD2L). LGMD2L is a genetic disorder characterized by progressive muscle weakness and wasting primarily affecting the muscles of the shoulders and hips.

NGS (Next-Generation Sequencing) Genetic Test refers to a type of genetic testing that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of LGMD2L, an NGS Genetic Test would involve sequencing the ANO5 gene to identify any mutations or variations that may be associated with the condition.

By analyzing the ANO5 gene, an NGS Genetic Test can help confirm a diagnosis of LGMD2L and provide information about the specific genetic mutation causing the condition. This information can be valuable for genetic counseling, family planning, and potentially guiding treatment decisions.

It is important to note that genetic testing should be performed by a qualified healthcare professional or genetic counselor, who can interpret the results and provide appropriate guidance and support.